Related Experiment Videos
Human oocyte cryopreservation: a valid alternative to embryo cryopreservation?
Michael Tucker1, Paula Morton, Juergen Liebermann
1Georgia Reproductive Specialists, 5445 Meridian Mark Road, Suite 270, Atlanta, GA 30342, USA. mtucker@ivf.com
Summary
Oocyte cryopreservation offers a solution to ethical and practical issues associated with embryo freezing in infertility therapy. This approach may soon become standard practice, improving outcomes for in vitro fertilization (IVF).
Area of Science:
- Reproductive Medicine
- Cryobiology
- In Vitro Fertilization (IVF)
Background:
- Human in vitro fertilization (IVF) has evolved, necessitating embryo cryopreservation due to ethical considerations and the drive to maximize oocyte yield.
- Current IVF practices, including the collection of multiple oocytes and subsequent embryo creation, lead to surplus embryos, raising ethical dilemmas and practical challenges like co-ownership disputes.
- The trend towards single embryo transfers and improving embryonic viability makes the production of excessive surplus embryos increasingly inappropriate.
Purpose of the Study:
- To explore oocyte cryopreservation as a viable alternative to embryo cryopreservation in IVF therapy.
- To address the ethical concerns and practical complications associated with current embryo cryopreservation methods.
- To evaluate the potential of oocyte cryopreservation in optimizing donor oocyte banking and preserving reproductive potential.
Main Methods:
- Review of current practices in human in vitro fertilization (IVF) and embryo cryopreservation.
- Analysis of the ethical and legal challenges posed by cryopreserved embryos.
- Discussion of advancements in oocyte cryopreservation technologies, including vitrification and in vitro maturation.
Main Results:
- Oocyte cryopreservation offers a potential solution to ethical concerns regarding embryo freezing and legal issues arising from separated couples.
- Vitrification technology and standardization of protocols are advancing routine single oocyte cryostorage at all maturity stages.
- Oocyte cryopreservation can optimize donor oocyte banking, reduce costs, and improve convenience compared to frozen embryo donation.
Conclusions:
- Oocyte cryopreservation, coupled with in vitro maturation, is moving towards routine clinical application, potentially reducing the need for excess embryo production.
- This shift will enable IVF programs to consider cryostoring excess oocytes instead of embryos, inseminating a limited number post-thaw.
- The widespread clinical application of human oocyte cryostorage is anticipated in the near future, transforming IVF practices.